Zobrazeno 1 - 10
of 43
pro vyhledávání: '"J. R. Germa Lluch"'
Autor:
Xavier Garcia del Muro, Regina Gironés, José García-Sánchez, Enrique Gonzalez-Billalabeitia, Montserrat Domenech, Roma Bastus, Naiara Sagastibelza, J. R. Germa-Lluch, Josep Guma, J. A. Meana, Alfredo Sanchez, Jorge Aparicio, J. Terrasa, Alfonso Sánchez-Muñoz, Sebastián Ochenduszko
Publikováno v:
Oncology. 95:8-12
Objective: The aim of this study was to assess a risk-adapted strategy for stage I seminoma guided by the presence of rete testis invasion. Methods: Between January 2013 and December 2015, a total of 135 consecutive patients with stage I seminoma fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8103111815ba2c595ce269f249780f
https://doi.org/10.1159/000487438
https://doi.org/10.1159/000487438
Autor:
M. De Santis, Friedemann Honecker, Anja Lorch, T. Tandstad, D. Ondruš, Alan Horwich, J. R. Germa-Lluch, Silke Gillessen, Michael Cullen, Giovanni Rosti, Timothy D. Gilligan, Jorge Aparicio, Gabriella Cohn-Cedermark, U. De Giorgi, Sophie D. Fosså, Jan Oldenburg, Hege Sagstuen Haugnes, Andrew J. Stephenson, Jörg Beyer, R. de Wit
Publikováno v:
Annals of Oncology, 26(5), 833-838. Elsevier Ltd.
Testicular cancer (TC) is the most common neoplasm in males aged 15-40 years. The majority of patients have no evidence of metastases at diagnosis and thus have clinical stage I (CSI) disease [Oldenburg J, Fossa SD, Nuver J et al. Testicular seminoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2afa98f7a3841b47b2761b7153b85012
https://doi.org/10.1093/annonc/mdu514
https://doi.org/10.1093/annonc/mdu514
Autor:
Margarita Majem, Ricard Mis, Marisa Martinez, Carme Muñoz, Margarita García, Carmen Cuadra, Ramon Salazar, Ana Clopés, Beatriz Pardo, Ana Montes, Claudio Savulsky, J. R. Germa-Lluch
Publikováno v:
Journal of Liposome Research. 19:261-266
As a dose-finding phase I study of a new liposomal formulation of doxorubicin (LipD), patients (n = 39; median age: 60 years; range, 41-75; median ECOG performance status, 1; range, 0-2) with refractory cancer had a starting dose of LipD administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c606395caa97015161b78a88d9e355
https://doi.org/10.3109/08982100902804833
https://doi.org/10.3109/08982100902804833
Autor:
N. Nicolai, O. Leiva, Johnathan K Joffe, O. Klepp, P. Walz, Rolf Mueller, M. de Wit, S. Clemm, S. D. Fossa, Niels E. Skakkebæk, Gedske Daugaard, Robert Huddart, S. Tjulandin, M. Kuczyk, S. Krege, M. D. Mason, G. Kaiser, X. Garcia del Muro, László Kisbenedek, Gosse O N Oosterhof, O. Rick, Wolfgang Hoeltl, S. Kliesch, H. von der Maase, M. Bamberg, A. Gerl, N. Aass, Christian Kollmannsberger, G. Pizzocaro, M. Hartmann, L. Weissbach, O. Pont, U. Studer, P. Albers, M.P. Laguna, V. Loy, R. Souchon, H.-J. Schmoll, J. P. Droz, P.H.M. de Mulder, Heinz Schmidberger, Jörg Beyer, K. Fizazi, Tobias Pottek, J. Classen, G. M. Mead, Alan Horwich, L. Paz Ares, C. Bokemeyer, W. Jones, Eva Winter, T. Oliver, H. G. Derigs, J. R. Germa-Lluch, Felix Sedlmayer, István Bodrogi, Stefan Weinknecht, M. Flasshove, A. Heidenreich, F. Algaba, R. de Wit, S. Culine, K. U. Koehrmann, C. Wittekind, J. T. Hartmann, K. P. Dieckmann, W. Siegert, G. Rosti
Publikováno v:
Annals of Oncology, 15, 9, pp. 1377-99
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise in the incidence every 20 years. Despite this, the high sensitivity of germ cell tumours to platinum-based chemotherapy, together with radiation and surgical me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03402bbd11b08d48e88c2f718a1ae54e
https://doi.org/10.1093/annonc/mdh301
https://doi.org/10.1093/annonc/mdh301
Autor:
A J Zurita, Javier Pérez, X. Garcia del Muro, Miguel Izquierdo, George L. Scheffer, R.J. Scheper, J. R. Germa-Lluch, Enric Condom, Julio E. Diestra
Publikováno v:
British Journal of Cancer
Zurita, AJ, Diestra, JE, Condom, E, Garcia Del Muro, X, Scheffer, G L, Scheper, R J, Perez, J, Germa-Lluch, JR & Izquierdo, M A 2003, ' Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours. ', British Journal of Cancer, vol. 88, no. 6, pp. 879-86 . https://doi.org/10.1038/sj.bjc.6600803
British Journal of Cancer, 88(6), 879-86. Nature Publishing Group
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Zurita, AJ, Diestra, JE, Condom, E, Garcia Del Muro, X, Scheffer, G L, Scheper, R J, Perez, J, Germa-Lluch, JR & Izquierdo, M A 2003, ' Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours. ', British Journal of Cancer, vol. 88, no. 6, pp. 879-86 . https://doi.org/10.1038/sj.bjc.6600803
British Journal of Cancer, 88(6), 879-86. Nature Publishing Group
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
This study was undertaken to investigate the expression and predictive value for outcome of multidrug resistance-associated (MDR) proteins P-glycoprotein (Pgp), MRP1, BCRP, and LRP, in advanced testicular germ-cell tumours (TGCT). Paraffin-embedded s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5388823b17e2afa55d0fa15432b8439d
http://europepmc.org/articles/PMC2377094
http://europepmc.org/articles/PMC2377094
Autor:
D. Almenar, Jorge Aparicio, A. Saenz, R. Lasso de la Vega, J. R. Germa-Lluch, Josep Guma, Javier Sastre, J. A. Arranz, Agust Barnadas, X. Perez, J. Terrassa, Miguel Angel Climent, Marta López-Brea, Pablo Maroto, X. García del Muro, Luis Paz-Ares, Miguel Ángel Martín Sánchez, Emilio Alba, A.M. Arance Fernandez, G. Berenguer
Publikováno v:
European Urology. 42:553-563
Objective: To describe the clinical characteristics and treatment results obtained with the application of a homogeneous treatment protocol in 1490 patients with germ-cell tumours (GCT) registered in the 55 hospitals belonging to the Spanish Germ-Cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7faedf2ae049835b12900f45bc8aa8cc
https://doi.org/10.1016/s0302-2838(02)00439-6
https://doi.org/10.1016/s0302-2838(02)00439-6
Autor:
Sergio Vazquez-Estevez, X. Garcia del Muro, J. P. Maroto, Alfredo Sanchez-Hernandez, A. Saenz, Enrique Gallardo, N. Sagastibelza, J.A. Arranz Arija, Alba Hernández, Jorge Aparicio, D. Almenar-Cubells, Javier Sastre, J. Terrasa, J. R. Germa-Lluch, M. López Brea, Carmen Santander, Elena Cillan, Enrique Gonzalez-Billalabeitia, Regina Gironés, P. Roure
Publikováno v:
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Brain metastases of testicular germ cell tumor (TGCT) are a rare event. Prognostic is poor and there is not much evidence on optimal management of these patients. A review of case records of germ cell tumor patients within the Spanish Germ Cell Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66063b6d2c08c28aebe36f2142347e47
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8824
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8824
Autor:
M, Bachner, Y, Loriot, M, Gross-Goupil, P A, Zucali, A, Horwich, J-R, Germa-Lluch, C, Kollmannsberger, F, Stoiber, A, Fléchon, K, Oechsle, S, Gillessen, J, Oldenburg, G, Cohn-Cedermark, G, Daugaard, F, Morelli, A, Sella, S, Harland, M, Kerst, J, Gampe, C, Dittrich, K, Fizazi, M, De Santis
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 23(1)
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac3cc33589e24a5b60337f357bc198fb
https://pubmed.ncbi.nlm.nih.gov/21460378
https://pubmed.ncbi.nlm.nih.gov/21460378
Autor:
Pablo Maroto, Jorge Aparicio, Robert Huddart, L. Paz Ares, Alan Horwich, J. R. Germa-Lluch, X. Garcia del Muro
Publikováno v:
ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Purpose: To determine the activity and toxicity of temozolomide in a phase II multicenter trial in patients diagnosed with relapsed or cisplatin-refractory germ cell tumors. Patients and Methods: During a recruitment period of 30 months, 20 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f06ba271175fd6f4fde8aea1fcae8b7
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11925
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11925
Autor:
A. Fermández Sagarra, J. R. Germa Lluch, R. Blanco Guerrero, M. A. Climent Duran, Humberto Villavicencio, F. J. Sole Balcells, M.A. Segui Palmer
Publikováno v:
European Urology. 21:287-293
Forty-one patients with poor-prognosis nonseminomatous germ cell tumors (NSGCT) of the testis were treated between 1980 and 1989. This group was defined by the presence of one of the following features: multiple large lung metastases, bone, liver or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a96b1bb996ee61d027811b12ac2c85
https://doi.org/10.1159/000474859
https://doi.org/10.1159/000474859